Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1426935rdf:typepubmed:Citationlld:pubmed
pubmed-article:1426935lifeskim:mentionsumls-concept:C0085979lld:lifeskim
pubmed-article:1426935lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:1426935lifeskim:mentionsumls-concept:C0001480lld:lifeskim
pubmed-article:1426935lifeskim:mentionsumls-concept:C0042523lld:lifeskim
pubmed-article:1426935lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:1426935lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1426935lifeskim:mentionsumls-concept:C0442796lld:lifeskim
pubmed-article:1426935lifeskim:mentionsumls-concept:C1330125lld:lifeskim
pubmed-article:1426935pubmed:issue5lld:pubmed
pubmed-article:1426935pubmed:dateCreated1992-12-4lld:pubmed
pubmed-article:1426935pubmed:abstractText1. A comparative study on isolated guinea pig hearts was carried out to determine the effects of ATP and verapamil as cardioplegic additives. 2. The hearts were arrested by one of the plegic solutions: I, potassium 20 mmol/l; II, potassium 20 mmol/l+verapamil 1.1 mumol/l; III, potassium 20 mmol/l+ATP 10 mmol/l. After 45 min of hypothermic ischemia, the hearts were reperfused by Krebs-Henseleit buffer. 3. Postischemic percentage change of myocardial functions (heart rate, contractility, heart work) and tissue enzymes (LDH, SGOT, SGPT) were compared between the groups. 4. Although a rapid cardiac arrest could be obtained by verapamil added cardioplegia. Postischemic myocardial recovery was much better with ATP added cardioplegic solutions.lld:pubmed
pubmed-article:1426935pubmed:languageenglld:pubmed
pubmed-article:1426935pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1426935pubmed:citationSubsetIMlld:pubmed
pubmed-article:1426935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1426935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1426935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1426935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1426935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1426935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1426935pubmed:statusMEDLINElld:pubmed
pubmed-article:1426935pubmed:monthSeplld:pubmed
pubmed-article:1426935pubmed:issn0306-3623lld:pubmed
pubmed-article:1426935pubmed:authorpubmed-author:ErsözAAlld:pubmed
pubmed-article:1426935pubmed:authorpubmed-author:GökgözLLlld:pubmed
pubmed-article:1426935pubmed:authorpubmed-author:KarasuCClld:pubmed
pubmed-article:1426935pubmed:authorpubmed-author:SonculHHlld:pubmed
pubmed-article:1426935pubmed:authorpubmed-author:AyranciogluKKlld:pubmed
pubmed-article:1426935pubmed:authorpubmed-author:KalayciogluSSlld:pubmed
pubmed-article:1426935pubmed:issnTypePrintlld:pubmed
pubmed-article:1426935pubmed:volume23lld:pubmed
pubmed-article:1426935pubmed:ownerNLMlld:pubmed
pubmed-article:1426935pubmed:authorsCompleteYlld:pubmed
pubmed-article:1426935pubmed:pagination909-13lld:pubmed
pubmed-article:1426935pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:1426935pubmed:meshHeadingpubmed-meshheading:1426935-...lld:pubmed
pubmed-article:1426935pubmed:meshHeadingpubmed-meshheading:1426935-...lld:pubmed
pubmed-article:1426935pubmed:meshHeadingpubmed-meshheading:1426935-...lld:pubmed
pubmed-article:1426935pubmed:meshHeadingpubmed-meshheading:1426935-...lld:pubmed
pubmed-article:1426935pubmed:meshHeadingpubmed-meshheading:1426935-...lld:pubmed
pubmed-article:1426935pubmed:meshHeadingpubmed-meshheading:1426935-...lld:pubmed
pubmed-article:1426935pubmed:meshHeadingpubmed-meshheading:1426935-...lld:pubmed
pubmed-article:1426935pubmed:meshHeadingpubmed-meshheading:1426935-...lld:pubmed
pubmed-article:1426935pubmed:meshHeadingpubmed-meshheading:1426935-...lld:pubmed
pubmed-article:1426935pubmed:meshHeadingpubmed-meshheading:1426935-...lld:pubmed
pubmed-article:1426935pubmed:meshHeadingpubmed-meshheading:1426935-...lld:pubmed
pubmed-article:1426935pubmed:meshHeadingpubmed-meshheading:1426935-...lld:pubmed
pubmed-article:1426935pubmed:meshHeadingpubmed-meshheading:1426935-...lld:pubmed
pubmed-article:1426935pubmed:year1992lld:pubmed
pubmed-article:1426935pubmed:articleTitleEffect of ATP and verapamil as cardioplegic additives in the isolated guinea pig heart.lld:pubmed
pubmed-article:1426935pubmed:affiliationDepartment of Thoracic and Cardiovascular Surgery, Gazi University Medical School, Ankara, Turkey.lld:pubmed
pubmed-article:1426935pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1426935pubmed:publicationTypeComparative Studylld:pubmed